News | Cardiovascular Business | January 17, 2017

ECRI Institute Announces New Mergers and Acquisitions Service

New service helps merging healthcare organizations realize immediate and long-term savings on supply-side and medical capital expenses

ECRI Institute, mergers and acquisitions service

January 17, 2017 — ECRI Institute announced a new mergers and acquisitions service that empowers new hospital alliances to control their spending and plan for the future by eliminating waste and redundancy in medical-surgical supplies and capital medical equipment.

The No. 1 reason hospital mergers or acquisitions do not succeed, according to ECRI Institute, is failure to integrate. A precursor to any successful integration is a systematic review of contract portfolios and equipment inventories.

Unfortunately, many hospitals do not have the resources to perform a complete assessment in these areas — essentially risking millions of dollars in potential savings and inadvertently creating new safety and quality risks.

For supplies, ECRI Institute identifies the greatest opportunities for savings by negotiating to the lowest price available. For example, by analyzing purchase order histories and pricing data for merging organizations, ECRI Institute's price parity reports identified $3.2 million in potential savings for one transaction, and nearly $1.3 million for another.

ECRI experts highlight product categories with significant overlap and compare them to the categories that will require product conversion.

"With supply costs set to eclipse labor costs in just a few years, hospitals can use ECRI Institute's independent benchmarking capabilities and market analytics to negotiate the best pricing and deepest discounts from their suppliers," said Timothy Browne, director of ECRI Institute's PriceGuide service.

For capital equipment, the new service reduces expenditures by helping newly merged health systems develop a data-driven predictive replacement plan for equipment acquisition, replacement and redeployment.

Based on clinical, safety, operational and obsolescence criteria, the plan focuses on maximizing use of existing medical equipment and expanding capital availability in key technology areas such as radiology, surgery and cardiology.

In the case of one hospital system that was preparing to put itself on the market, ECRI Institute uncovered $6.7 million of potential capital savings from the redeployment, replacement and retirement of key technologies over a 12-month period.

For more information: www.ecri.org


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now